A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer

Clinical trial NCT00131638 · COMPLETED

Trial details

NCT number: NCT00131638
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2005-01-01
Primary completion: 2007-11-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.